Busitema University, Mbale, Uganda.
Infectious Disease Institute, Makerere University, Kampala, Uganda.
Infect Dis Poverty. 2020 Mar 2;9(1):12. doi: 10.1186/s40249-020-0628-3.
Around 2007, a nodding syndrome (NS) epidemic appeared in onchocerciasis-endemic districts of northern Uganda, where ivermectin mass distribution had never been implemented. This study evaluated the effect of community-directed treatment with ivermectin (CDTI) and ground larviciding of rivers initiated after 2009 and 2012 respectively, on the epidemiology of NS and other forms of epilepsy (OFE) in some districts of northern Uganda.
In 2012, a population-based community survey of NS/epilepsy was carried out by the Ugandan Ministry of Health in Kitgum and Pader districts. In August 2017, we conducted a new survey in selected villages of these districts and compared our findings with the 2012 data. In addition, two villages in Moyo district (where CDTI was ongoing since 1993) served as comparative onchocerciasis-endemic sites in which larviciding had never been implemented. The comparison between 2012 and 2017 prevalence and cumulative incidence were done using the Fisher's and Pearson's Chi-square tests at 95% level of significance.
A total of 2138 individuals in 390 households were interviewed. In the selected villages of Kitgum and Pader, there was no significant decrease in prevalence of NS and OFE between 2012 and 2017. However, the cumulative incidence of all forms of epilepsy decreased from 1165 to 130 per 100 000 persons per year (P = 0.002); that of NS decreased from 490 to 43 per 100 000 persons per year (P = 0.037); and for OFE from 675 to 87 per 100 000 persons per year (P = 0.024). The median age of affected persons (NS and OFE) shifted from 13.5 (IQR: 11.0-15.0) years in 2012 to 18.0 (IQR: 15.0-20.3) years in 2017; P < 0.001. The age-standardized prevalence of OFE in Moyo in 2017 was 4.6%, similar to 4.5% in Kitgum and Pader.
Our findings support the growing evidence of a relationship between infection by Onchocerca volvulus and some types of childhood epilepsy, and suggest that a combination of bi-annual mass distribution of ivermectin and ground larviciding of rivers is an effective strategy to prevent NS and OFE in onchocerciasis-hyperendemic areas.
大约在 2007 年,乌干达北部的盘尾丝虫病流行地区出现了点头综合征(NS)疫情,而那里从未实施过伊维菌素大规模分发。本研究评估了分别于 2009 年和 2012 年启动的社区定向伊维菌素治疗(CDTI)和河流地面幼虫防治对乌干达北部一些地区 NS 和其他形式癫痫(OFE)的流行病学的影响。
2012 年,乌干达卫生部在基特古姆和帕德尔区进行了一项基于人群的 NS/癫痫社区调查。2017 年 8 月,我们在这些区的选定村庄进行了一项新的调查,并将我们的发现与 2012 年的数据进行了比较。此外,莫约区的两个村庄(自 1993 年以来一直在进行 CDTI)作为比较盘尾丝虫病流行地区,从未进行过幼虫防治。2012 年和 2017 年患病率和累积发病率的比较采用 Fisher 和 Pearson 的卡方检验,显著性水平为 95%。
共对 390 户家庭的 2138 人进行了访谈。在基特古姆和帕德尔的选定村庄,NS 和 OFE 的患病率在 2012 年至 2017 年之间没有显著下降。然而,所有形式癫痫的累积发病率从每年每 100000 人 1165 例降至 130 例(P=0.002);NS 从每年每 100000 人 490 例降至 43 例(P=0.037);OFE 从每年每 100000 人 675 例降至 87 例(P=0.024)。受影响者(NS 和 OFE)的年龄中位数从 2012 年的 13.5(IQR:11.0-15.0)岁转移到 2017 年的 18.0(IQR:15.0-20.3)岁;P<0.001。2017 年莫约的 OFE 年龄标准化患病率为 4.6%,与基特古姆和帕德尔的 4.5%相似。
我们的研究结果支持了感染旋盘尾丝虫与某些类型的儿童癫痫之间存在关联的证据越来越多,并表明每两年进行一次伊维菌素大规模分发和河流地面幼虫防治相结合是预防盘尾丝虫病流行地区 NS 和 OFE 的有效策略。